Skip to main content

GOLDMAN SACHS GROUP INC

Position in EOLS — Evolus, Inc.

CIK 886982 NEW YORK, NY

Position in EOLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,465,095
+$2,132,662 QoQ
Shares Held
1,086,398
+209.7% QoQ
Ownership
1.65%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $1,741,757,397 across 53 Drug Manufacturers - Specialty & Generic names. EOLS ranks #36 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EOLS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,465,095 1,086,398
2025-12-31 $2,332,433 350,742
2025-09-30 $2,810,258 457,697
2025-06-30 $2,732,643 296,704
2025-03-31 $4,353,897 361,920
2024-12-31 $4,589,073 415,677
2024-09-30 $5,031,427 310,582
2024-06-30 $1,672,613 154,158
2024-03-31 $2,607,850 186,275
2023-12-31 $1,456,435 138,313
2023-09-30 $1,573,450 172,150
2023-06-30 $1,240,486 170,631
2023-03-31 $1,150,550 135,999
2022-12-31 $1,003,283 133,593
2022-09-30 $738,457 91,734
2022-06-30 $1,722,413 148,484
2022-03-31 $1,004,649 89,541
2021-12-31 $1,959,561 301,008
2021-09-30 $2,220,216 291,367
2021-06-30 $4,002,168 316,377
2021-03-31 $951,854 73,276
2020-12-31 $128,476 38,237
2020-09-30 $134,163 34,313
2020-06-30 $140,900 26,585
2020-03-31 $206,029 49,646